Advertisement

Dual use of condoms and contraceptives in the USA.

23:40 EDT 19th June 2013 | BioPortfolio

Summary of "Dual use of condoms and contraceptives in the USA."

Background Use of condoms in conjunction with other contraceptive methods has multiple benefits: prevention of unintended pregnancy, protection against sexually transmissible infections (STI), and sequentially, defence against the threat of infertility. However, few reviews compare dual method use prevalence or trends or systematically review the facilitators and barriers of dual method use across multiple studies. Methods: The authors review the literature on trends and covariates of dual method use in the USA among both nationally representative and smaller samples. Results: Although dual method use prevalence estimates vary widely across study populations, nationally representative estimates are consistently lower than Western European countries, who in turn report lower rates of unintended pregnancies and STI. The majority of published work on dual method use focuses on adolescents. Prior studies have associated dual method use with a range of individual-level factors: socio-demographic variables, such as younger age; STI risk behaviours and risk perception; relationship variables, such as number of partners, relationship length, and partner support of condoms; and educational factors, such as prior exposure to HIV prevention messages. Conclusions: Although dual method use appears to be on the rise, especially among adolescents and young adults, US rates are comparatively low and leave much room for improvement. This review identifies several populations most in need of intervention. However, we encourage public health practitioners to evolve beyond individual-level studies and interventions to focus on the relational, socio-cultural, and structural influences on dual method use. Dual use promotion programs and policies should also equally target men and women, adolescents and adults.

Affiliation

Heilbrunn Department of Population and Family Health, Columbia University, New York, NY 10032, USA.

Journal Details

This article was published in the following journal.

Name: Sexual health
ISSN: 1448-5028
Pages: 73-80

Links

Medical and Biotech [MESH] Definitions

Contraceptives, Postcoital, Hormonal

Postcoital contraceptives which owe their effectiveness to hormonal preparations.

Contraceptives, Postcoital, Synthetic

Postcoital contraceptives which owe their effectiveness to synthetic preparations.

Contraceptives, Oral, Hormonal

Oral contraceptives which owe their effectiveness to hormonal preparations.

Contraceptives, Oral, Synthetic

Oral contraceptives which owe their effectiveness to synthetic preparations.

Dual Specificity Phosphatase 3

A dual specificity phosphatase subtype that plays a role in intracellular signal transduction by inactivating MITOGEN-ACTIVATED PROTEIN KINASES. It has specificity for EXTRACELLULAR SIGNAL-REGULATED MAP KINASES.

PubMed Articles [ 2691 Associated PubMed Articles listed on BioPortfolio]

The effect of different hormonal contraceptives on plasma levels of free protein S and free TFPI.

Use of combined oral contraceptives is associated with a three- to six-fold increased risk of venous thrombosis. Hormonal contraceptives induce acquired resistance to activated protein C (APC), which...

Hormonal Contraception and HIV-1 Transmission.

Citation Blish CA, Baeten JM. Hormonal contraception and HIV-1 transmission. Am J Reprod Immunol 2010 Safe and effective contraceptive choices are essential for women with HIV-1 infection and at risk...

Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2010: Revised Recommendations for the Use of Hormonal Contraception Among Women at High Risk for HIV Infection or Infected with HIV.

Prevention of unintended pregnancy among women at risk for human immunodeficiency virus (HIV) infection or infected with HIV is critically important. One strategy for preventing unintended pregnancies...

Changing Oral Contraceptives from Prescription to Over-the-Counter Status: An Opinion Statement of the Women's Health Practice and Research Network of the American College of Clinical Pharmacy.

Abstract Addressing the issue of unintended pregnancy is a national priority. One proposed strategy to reduce unintended pregnancy is to improve access to oral contraceptives by changing them to over-...

Protrhombotic Effects of Contraceptives.

The use of oral contraceptives first became widespread some 40 years ago, and reports of an excess risk of cardiovascular disease among women who used these agents soon followed. Few drugs have been t...

Clinical Trials [ 340 Associated Clinical Trials listed on BioPortfolio]

Effects of Drospirenone-containing or -Not Containing Combined Oral Contraceptives on General and Sexual Well-being

The purpose of this study is to evaluate the symptoms and satisfaction for women taking drospirenone (DRSP)-containing combined oral contraceptives in comparison with women taking other ki...

Long-Term Active Surveillance Study for Oral Contraceptives (LASS)

The objective of this study is to characterize and compare the risks of long-term use of oral contraceptives containing drospirenone and of other established oral contraceptives.

A Drug-drug Interaction Study to Investigate the Effects of AZD1981 on the Metabolism and Pharmacodynamics of Oral Contraceptives

The primary purpose of this study is to determine whether the treatment with AZD1981 will affect the metabolism of hormones included in oral contraceptives.

Randomised Controlled Trial of Condoms Plus Additional Lubrication

This RCT compares the clinical and non clinical condom failure rate among condom using heterosexual couples with and without externally applied additional spermicidal lubricant. The hypoth...

Use of Oral Contraceptives (OCs) Containing Dienogest and Risk of Venous Thromboembolism

The objective of this study is to compare the risk of venous thromboembolism (VTE) of oral contraceptives with non-use, focusing specifically on Valette® compared to other users of low es...

Search BioPortfolio: